IL103478A0 - Therapeutic agent - Google Patents

Therapeutic agent

Info

Publication number
IL103478A0
IL103478A0 IL92103478A IL10347892A IL103478A0 IL 103478 A0 IL103478 A0 IL 103478A0 IL 92103478 A IL92103478 A IL 92103478A IL 10347892 A IL10347892 A IL 10347892A IL 103478 A0 IL103478 A0 IL 103478A0
Authority
IL
Israel
Prior art keywords
therapeutic agent
compound
acridinedione
cyanophenyl
hexahydro
Prior art date
Application number
IL92103478A
Other languages
English (en)
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919122305A external-priority patent/GB9122305D0/en
Priority claimed from GB929213538A external-priority patent/GB9213538D0/en
Application filed by Ici Plc filed Critical Ici Plc
Publication of IL103478A0 publication Critical patent/IL103478A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/06Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/06Anti-spasmodics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL92103478A 1991-10-21 1992-10-20 Therapeutic agent IL103478A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919122305A GB9122305D0 (en) 1991-10-21 1991-10-21 Therapeutic agents
GB929213538A GB9213538D0 (en) 1992-06-25 1992-06-25 Therapeutic agent

Publications (1)

Publication Number Publication Date
IL103478A0 true IL103478A0 (en) 1993-03-15

Family

ID=26299722

Family Applications (1)

Application Number Title Priority Date Filing Date
IL92103478A IL103478A0 (en) 1991-10-21 1992-10-20 Therapeutic agent

Country Status (18)

Country Link
US (1) US5258390A (de)
EP (1) EP0539153B1 (de)
JP (1) JP3157924B2 (de)
KR (1) KR930007907A (de)
AT (1) ATE152103T1 (de)
AU (1) AU659500B2 (de)
CA (1) CA2080950A1 (de)
CZ (1) CZ317592A3 (de)
DE (2) DE69223736T2 (de)
FI (1) FI924744L (de)
GB (1) GB9220570D0 (de)
HU (1) HUT65626A (de)
IL (1) IL103478A0 (de)
MY (1) MY106661A (de)
NO (1) NO178696C (de)
NZ (1) NZ244822A (de)
PL (1) PL169716B1 (de)
TW (1) TW223061B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9214120D0 (en) * 1991-07-25 1992-08-12 Ici Plc Therapeutic amides
CA2080949A1 (en) * 1991-10-21 1993-04-22 Cyrus John Ohnmacht Therapeutic agents
US5455253A (en) * 1992-10-20 1995-10-03 Zeneca Limited Heterocyclic derivatives
GB9318935D0 (en) * 1992-10-20 1993-10-27 Zeneca Ltd Heterocyclic derivatives
GB9310069D0 (en) * 1993-05-17 1993-06-30 Zeneca Ltd Heterocyclic compounds
GB9407432D0 (en) * 1994-04-14 1994-06-08 Zeneca Ltd Heterocyclic derivative
EP0820288B1 (de) 1995-03-03 2004-02-11 Endo Pharmaceuticals Inc. Verwendung von dextromethorphan oder dextrorphan zur behandlung der harninkontinenz
GB9707695D0 (en) * 1996-08-07 1997-06-04 Hoffmann La Roche Tricyclic dione derivatives
US7030096B1 (en) * 1997-02-13 2006-04-18 Albert Einstein College Of Medicine Of Yeshiva University Method of enhancing relaxation of penile smooth muscle by introduction of DNA encoding maxi-K potassium channel protein
US6642222B2 (en) 1998-10-28 2003-11-04 Abbott Laboratories Pyrano, piperidino, and thiopyrano compounds and methods of use
AU1459500A (en) * 1998-10-28 2000-05-15 Abbott Laboratories Dihydropyridine compounds and methods of use
US6191140B1 (en) * 1998-10-28 2001-02-20 Abbott Laboratories Pyrano, piperidino, and thiopyrano compounds and methods of use
US6518279B2 (en) 1999-03-04 2003-02-11 Abbott Laboratories Cyclopentanone dihydropyridine compounds useful as potassium channel openers
TWI287984B (en) * 2000-10-17 2007-10-11 Wyeth Corp Pharmaceutical composition for modulating bladder function
AR033095A1 (es) 2001-04-04 2003-12-03 Wyeth Corp Metodos para el tratamiento de motilidad gastrica hiperactiva
EP1688141A1 (de) 2005-01-31 2006-08-09 elbion AG Verwendung von Flupirtine zur Behandlung der hyperaktiven Blase und damit zusammenhängender Erkrankungen und zur Behandlung des Reizdarmsyndroms
EP1896112A4 (de) * 2005-06-07 2011-04-27 A M S Res Corp Injektionsführsystem und verfahren
DE602007003697D1 (de) 2006-02-10 2010-01-21 Janssen Pharmaceutica Nv Ffner

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3454577A (en) * 1965-11-09 1969-07-08 Hoffmann La Roche 4-(1,2,3,4,5,6,7,8 - octahydro - 1,8 - dioxo-9-acridanyl) - benzenesulfonamide and derivatives
DE2003148A1 (de) * 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
DE2018738A1 (en) * 1970-04-18 1971-10-28 Farbenfabriken Bayer Ag, 5090 Leverkusen Hydrogenated pyridines, quinolines andacridi
US4021434A (en) * 1972-01-22 1977-05-03 Yamanouchi Pharmaceutical Co., Ltd. Sodium β-[2,6-dimethyl-3,5-bis(ethoxycarbonyl)-4-(3-nitrophenyl)-1,4-dihydropyridine-1-yl]ethyl sulfate
DE2242106A1 (de) * 1972-08-26 1974-03-21 Agfa Gevaert Ag Lichtempfindliches photographisches material
DE2718130C2 (de) * 1977-04-23 1979-05-17 Du Pont De Nemours (Deutschland) Gmbh, 4000 Duesseldorf lichtempfindliches Aufzeichnungsmaterial
US4546186A (en) * 1983-12-14 1985-10-08 American Home Products Corporation 1,4,5,6,7,8-Hexahydro-2-methyl-5-oxo-4-(2-thiazolyl)-3-quinoline carboxylic acid 2-methyl(phenylmethyl)amino ethyl ester and pharmaceutically acceptable salts

Also Published As

Publication number Publication date
AU2713992A (en) 1993-04-22
CA2080950A1 (en) 1993-04-22
EP0539153B1 (de) 1997-04-23
DE69219271T2 (de) 1997-08-07
KR930007907A (ko) 1993-05-20
AU659500B2 (en) 1995-05-18
HUT65626A (en) 1994-07-28
PL296229A1 (en) 1993-10-04
NO178696B (no) 1996-02-05
GB9220570D0 (en) 1992-11-11
DE69223736T2 (de) 1998-05-07
EP0539153A1 (de) 1993-04-28
DE69223736D1 (de) 1998-02-05
JP3157924B2 (ja) 2001-04-23
HU9203288D0 (en) 1992-12-28
TW223061B (en) 1994-05-01
PL169716B1 (pl) 1996-08-30
ATE152103T1 (de) 1997-05-15
NO924066L (no) 1993-04-22
MY106661A (en) 1995-07-31
FI924744A0 (fi) 1992-10-20
CZ317592A3 (en) 1993-05-12
US5258390A (en) 1993-11-02
NZ244822A (en) 1994-10-26
NO178696C (no) 1996-05-15
NO924066D0 (no) 1992-10-20
FI924744A7 (fi) 1993-04-22
FI924744L (fi) 1993-04-22
DE69219271D1 (de) 1997-05-28
JPH05201986A (ja) 1993-08-10

Similar Documents

Publication Publication Date Title
GB9220570D0 (en) Therapeutic agent
CA2263561A1 (en) Thienopyrimidines
CA2125888A1 (en) Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis following angioplasty
GB9214120D0 (en) Therapeutic amides
TW273550B (de)
MY103352A (en) Piperazinyl-heterocyclic compounds
GR3026218T3 (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro derivatives of alpha D-neuraminic acid
CA2269815A1 (en) Thienopyrimidines having pde v-inhibiting action
PH30526A (en) Dispersable formulation comprising diclofenac
PH30083A (en) Treatment of lower urinary tract disorders
ATE161531T1 (de) Acridine-1,8-dionderivate als therapeutisches mittel
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
HU9500262D0 (en) New pharmaceutical compositions containing 3-phenyl-sulfonyl-3,7-diazabicyclo[3.3.1]nonane compounds
HU9400908D0 (en) Pharmaceutical compositions for treatng skin disorders
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
GR3025797T3 (en) New carboxylic-acid esters of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, the preparation of such esters and their use
IL85231A0 (en) Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones,a process for the preparation thereof,pharmaceutical compositions containing same and the use thereof
EP0246573A3 (en) Pharmaceutical composition containing a 8-chlorobenzothiazepine compound and its use
MX9205778A (es) Agente terapeutico.
WO1999005106A8 (fr) Nouveaux derives benzamides stimulants de la motricite gastrointestinale haute et basse
IT1262567B (it) Pirrolidin-2-oni,loro preparazione,composizioni farmaceutiche che li contengono e loro uso in terapia.
RU92004356A (ru) Производные 1,8-акридиндиона, полезные как терапевтическое средство для лечения недержания мочи, и способ его получения
GB8912293D0 (en) Radiotherapeutic agent for the treatment of leukaemias